Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Int Urogynecol J ; 33(11): 3061-3066, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-35013758

RESUMEN

INTRODUCTION AND HYPOTHESIS: The International Consultation on Incontinence Questionnaire (ICIQ) Bladder Diary (BD) is a standardized and validated diary, developed in the English language, designed to assess lower urinary tract symptoms (LUTS) in men and women. This study reports the translation, cross-cultural adaptation and validation process of this diary to the Portuguese language. METHODS: After translation and back-translation of the ICIQ-BD to Portuguese, 140 urologic patients were asked to fill in this 3-day diary as well as the Overactive Bladder questionnaire Short Form (OABqSF) and a questionnaire evaluating the difficulties in filling out the ICIQ-BD. A subset of 60 patients filled out a second diary with/without LUTS treatment in between (30 patients in each group). In addition, content validity, internal consistency, criterion and construct validity were tested. RESULTS: The Portuguese version of the ICIQ-BD showed adequate internal consistency (Cronbach's alpha of 0.78), and patients reported few difficulties in filling out this tool, answering most commonly 1 on a 1-6 scale of difficulty. Excellent test-retest reliability and responsiveness of the diary were observed when comparing the first diary to a second completed 2-6 weeks later. Criterion validity was also confirmed, given the good correlation with the OABqSF (Pearson's 0.386-0.447). Finally, construct validity was established through statistically significant concordance between data obtained in the BD with generally accepted theories. CONCLUSION: The present version of the ICIQ-BD is the first bladder diary successfully validated in the Portuguese language. It is a suitable and standardized tool for scientific research and diagnostic assessment of LUTS in adult men and women.


Asunto(s)
Síntomas del Sistema Urinario Inferior , Vejiga Urinaria Hiperactiva , Incontinencia Urinaria , Adulto , Femenino , Humanos , Lenguaje , Síntomas del Sistema Urinario Inferior/diagnóstico , Masculino , Portugal , Calidad de Vida , Derivación y Consulta , Reproducibilidad de los Resultados , Encuestas y Cuestionarios , Vejiga Urinaria , Vejiga Urinaria Hiperactiva/diagnóstico , Incontinencia Urinaria/diagnóstico
2.
Urology ; 154: e11-e12, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34010676

RESUMEN

Prostate Ewing sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) is extremely rare. Currently, a multimodal approach is recommended, although there is no standard treatment. Nevertheless, this tumor has a very poor prognosis, with the longest reported survival of 24 months. We present a case of locally advanced prostate ES/PNET in a 29-year-old male who was treated with a multimodal approach. The patient is alive and disease free, with a seven year follow-up, with very good quality of life. This exceptionally long survival may be the result of the very aggressive multimodal treatment chosen and described herein.


Asunto(s)
Neoplasias de la Próstata/terapia , Sarcoma de Ewing/terapia , Adulto , Supervivencia sin Enfermedad , Humanos , Masculino , Neoplasias de la Próstata/patología , Sarcoma de Ewing/patología , Factores de Tiempo
3.
Neurourol Urodyn ; 39(8): 2471-2479, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-32956506

RESUMEN

AIMS: Local anesthesia protocols for intradetrusor onabotulinum toxin A (BoNTA) injection lack standardization. We aimed to determine if an alkalinized lidocaine solution is more effective than lidocaine only. METHODS: Patients of both genders aged 18 or above enlisted for intradetrusor BoNTA injection (idiopathic, neurogenic, and bladder pain syndrome) were included in a double-blinded randomized controlled trial after obtaining their informed consent. All participants filled a bladder diary and a urine culture was performed. Subjects were randomized 1:1 to Protocol A (20 ml 2% lidocaine + 10 ml 8.4% sodium bicarbonate) or Protocol B (20 ml 2% lidocaine + 10 ml 0.9% saline solution). A Numeric Rating Scale (0-10) was used to assess the level of pain immediately after the procedure (primary endpoint). Secondary endpoints included pain after 1 h, urinary tract infection, acute urinary retention, and hematuria related to the procedure. RESULTS: A total of 116 patients were randomized. Baseline characteristics (age, sex, indication, and bladder diary parameters) of patients in Group A and B were similar. Pain scores at the end of the procedure were significantly lower with the alkalinized solution (Protocol A and B, respectively, 2.37 ± 0.31 vs. 4.44 ± 0.36, p < .01). No differences were observed 1 h after treatment (Protocol A and B, respectively, 0.54 ± 0.17 vs. 0.69 ± 0.19, p = .487). The only adverse event reported was mild-to-moderate self-limited hematuria in 15.4% of patients. CONCLUSIONS: The use of an alkalinized lidocaine solution has proven to be significantly superior to lidocaine only as local anesthesia before intradetrusor BoNTA injection, suggesting that this may be considered a first-line option.


Asunto(s)
Anestésicos Locales/administración & dosificación , Toxinas Botulínicas Tipo A/administración & dosificación , Lidocaína/administración & dosificación , Dolor/tratamiento farmacológico , Vejiga Urinaria Neurogénica/tratamiento farmacológico , Agentes Urológicos/administración & dosificación , Administración Intravesical , Adulto , Anciano , Anciano de 80 o más Años , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dimensión del Dolor
4.
Future Sci OA ; 6(2): FSO436, 2019 Dec 12.
Artículo en Inglés | MEDLINE | ID: mdl-32025327

RESUMEN

AIM: To evaluate prostate-specific antigen response (PSAr) defined as a ≥50% decrease in PSA concentration from the pretreatment value, as a prognostic factor in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA). METHODS: Retrospective evaluation of patients with mCRPC treated with AA. RESULTS: 124 patients were identified. Median overall survival and progression-free survival for patients achieving PSAr versus patients without PSAr were 29.3 versus 9.7 months and 17.0 versus 5.2 months, respectively. Multivariate analysis confirmed that PSAr correlated with better overall survival (hazard ratio: 0.19; 95% CI: 0.10-0.38; p < 0.001) and progression-free survival (hazard ratio: 0.24; 95% CI: 0.14-0.41; p < 0.001). CONCLUSION: PSAr can be utilized as prognostic and predictive factors in mCRPC patients treated with AA.

5.
Urol Int ; 100(4): 428-433, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29649817

RESUMEN

INTRODUCTION: Transobturator tape (TOT) surgery has been associated with increased overactive bladder (OAB) although much controversy exists. METHODS: In a cross-sectional study, women who underwent TOT surgery for pure stress incontinence (MonarcTM) answered the 6 questions of the symptom bother (SB) subscale of the OAB questionnaire - short form (OABq-SF) and an additional question regarding whether symptoms began after surgery. Women with SB score over the 4th quartile (≥30/100) were reassessed after a longer follow-up. Patients from primary care were recruited as controls. RESULTS: We recruited 213 patients (135 in the TOT group and 78 age-adjusted controls). The mean age of operated patients was 58.7 ± 10.1 years with a mean follow-up of 25.9 ± 13.2 months. OABq-SF SB scores did not differ between the TOT group and controls (respectively, 18.5 ± 30 and 15.5 ± 6.7, p = 0.202). A total of 48% patients reported no relationship between symptoms and surgery. Highly symptomatic operated patients were reassessed after a longer follow-up (46.3 ± 10.6 months). The mean score in the second follow-up (n = 25) was not statistically different from the first assessment (46.4 ± 22.7 and 58.1 ± 19.8, p = 0.059). CONCLUSIONS: Women who underwent TOT surgery did not show increased OAB SB scores when compared to controls. Our study suggests that OAB symptoms may thus be present but overlooked during initial clinical assessment.


Asunto(s)
Cabestrillo Suburetral/efectos adversos , Vejiga Urinaria Hiperactiva/prevención & control , Incontinencia Urinaria de Esfuerzo/cirugía , Adulto , Anciano , Estudios Transversales , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Encuestas y Cuestionarios , Resultado del Tratamiento , Vejiga Urinaria Hiperactiva/diagnóstico , Incontinencia Urinaria de Esfuerzo/complicaciones , Urodinámica
6.
Arch. pediatr. Urug ; 87(3): 198-209, set. 2016. ilus, tab
Artículo en Español | LILACS | ID: lil-796325

RESUMEN

El dolor es un problema de salud frecuentemente no reconocido e ignorado en pediatría.. Objetivo::reportar la prevalencia de dolor en niños hospitalizados: las 24 horas previas y en el momento de la entrevista. De los pacientes con dolor actual describir: intensidad y tratamiento indicado.. Metodología::estudio transversal, el 6/12/13 en el Centro Hospitalario Pereira Rossell (CHPR) y el 20/1/14 en otras instituciones del país. Se incluyeron los menores de 15 años hospitalizados. Se consideró paciente con dolor cuando el niño o su cuidador referían haberlo experimentado en las 24 horas previas y/o en el momento de la entrevista. Variables: edad, sexo, motivo de ingreso, trastorno cognitivo, tratamiento analgésico indicado, vía e intervalo de administración, tratamiento adyuvante y medidas no farmacológicas. La intensidad se evaluó mediante escalas.. Resultados::se encontraron: 168 niños hospitalizados, 109 en el CHPR; prevalencia de: dolor en las 24 horas previas: 35% (59/168) y en el momento de la encuesta: 15,5% (26/168). De los niños con dolor actual la intensidad era: leve 8/26, moderado 14/26 y severo 4/26. No tenían indicación de fármacos analgésicos: 9/26. El analgésico más indicado fue dipirona (11/17) y la asociación más prescripta: dipirona-ketoprofeno (5/17). Se constató: indicación de intervalo no adecuado: 7/17; vía intravenosa: 12/17; tratamiento adyuvante y medidas no farmacológicas: 1 cada uno.. Conclusiones::se constataron niños hospitalizados con dolor y déficits diversos en los tratamientos indicados. Es necesario que las instituciones sanitarias aborden este problema como parte de su política institucional.


Pain is a health problem often unrecognized and ignored in pediatrics. Objective: to report the prevalence of pain in hospitalized children: 24 hours before and during the interview. To describe intensity and prescribed treatment in patients with current pain. Methods: transversal study, on 06/12/13 at Pereira Rossell Hospital Center (PRHC) and on 20/1/14 in other institutions. Hospitalized children under 15 years old were included. “Patient in pain” was considered when the child or caregiver reported pain experienced in the previous 24 hours and/or at the time of the interview. Variables: age, gender, reason for admission, cognitive disorder, analgesic treatment indicated, route of administration, dosing interval, adjuvant and non-pharmacological treatments. Validated scales were used to assess intensity. Results: 168 hospitalized children, 109 at PRHC; prevalence of pain in the previous 24 hours: 35% (59/168) and during the interview: 15.5% (26/168). Intensity of pain found in children with current pain was: 8/26 mild, 14/26 moderate and 4/26 severe; 9/26 did not have any analgesic prescription. The most prescribed analgesic was: dipirone (11/17) and most prescribed association was: dipirone-ketoprofen (5/17). Interdose interval was inappropriate in 7/17; intravenous route of administration was indicated in 12/17; adjuvant and non-pharmacological treatments were found in one patient each. Conclusions: hospitalized children in pain and several problems in analgesic treatment prescription were found. Institutional policies directed to address this problem in management are needed.


Asunto(s)
Humanos , Masculino , Adolescente , Dimensión del Dolor , Niño Hospitalizado , Manejo del Dolor , Tramadol/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Dipirona/uso terapéutico , Cetoprofeno/uso terapéutico , Epidemiología Descriptiva , Estudios Transversales , Quimioterapia Combinada , Analgésicos Opioides/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA